Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: Circ Arrhythm Electrophysiol. 2016 Apr;9(4):10.1161/CIRCEP.115.003629 e003629. doi: 10.1161/CIRCEP.115.003629

Figure 1.

Figure 1

Figure 1

Figure 1

Evidence suggesting that anatomic vs electric left ventricular hypertrophy (LVH) is distinct entities that not only can overlap but also have independent effects on outcomes. A (adapted from Sundström et al13 with permission of the publisher Lippincott Williams & Wilkins. Copyright © 2001), risk of mortality associated with and without ECG LVH (Cornell product criteria, ECG+/ECG−) and echocardiographic LVH (echo+/echo−). B (adapted from Narayanan et al14 with permission of the publisher Elsevier. Copyright © 2001), the relatively small overlap between echo and ECG LVH among cases that suffered sudden cardiac death. C (adapted from Chrispin et al18 with permission of the publisher Elsevier. Copyright © 2001), the independent effects of ECG LVH on increased risk of atrial fibrillation (AF) even when adjusted for anatomic LVH.